Cannabis
Trulieve Opening Medical Marijuana Dispensary in Fort Myers, Florida
Trulieve Cannabis Corp. (CSE: TRUL) (OTCThemes 0QX: TCNNF) “Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States, today announced the opening of a new medical cannabis dispensary in Fort Myers, Florida. Located at 15620 Summerlin Rd., the doors will open at 9 a.m. on Wednesday, April 13, 2022.
Grand opening festivities throughout the day at the new dispensary will include numerous partner giveaways, music, food trucks, deals and specials, and all registered patients will receive a 25% discount. Trulieve also offers statewide home delivery, convenient online ordering and in-store pickup.
“Trulieve is excited to expand access to medical cannabis in the Fort Myers market and build strong relationships in the community,” said Kim Rivers, CEO of Trulieve. “Our company is driven by our commitment to providing tailored, high-quality patient care in a safe and comfortable environment.”
As the state’s leading medical cannabis provider, Trulieve’s retail employees are trained to provide personalized patient care and support individuals at every stage of their cannabis journey. Trulieve dispensaries throughout Florida offer on-site consultations to help patients obtain appropriate medical products and dosages to ensure optimal cannabis experiences.
Trulieve patients across Florida can choose from the largest selection of THC and CBD products available in a variety of consumption methods, including smokable flower, concentrates, edibles, capsules, syringes, tinctures, topical creams, vaporizers, and more. Patients have access to nationally-beloved brands such as Bellamy Brothers, Bhang, Binske, Blue River, Black Tuna, Love’s Oven, O.pen, and Sunshine Cannabis, all available exclusively at Trulieve in Florida.
For more information about additional Trulieve dispensary locations in Florida, how to become a registered patient, store activations and promotions, please visit www.trulieve.com/dispensaries/florida.
Cannabis
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
Cannabis
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
Cannabis
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect
-
Cannabis2 weeks ago
Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand
-
Innocan1 week ago
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
-
Curaleaf1 week ago
Curaleaf Completes Acquisition of Northern Green Canada
-
Cannabis1 week ago
Cannabis Capsule Global Analysis Report 2024: Market to Reach $79.2 Billion in 2028 – Forecast to 2033 Featuring GW Pharmaceuticals, Trulieve Cannabis, Green Thumb Industries, Tilray, Columbia Care
-
SCHWAZZE3 days ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 days ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 days ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace